| |
| |
|
| Insider
Information: |
Bienaime Jean Jacques |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
539,056 |
|
|
Indirect Shares
|
247,533 |
|
|
| Direct
Value |
$43,131,983 |
|
|
|
Indirect Value
|
$21,938,850 |
|
|
| Total
Shares |
786,589 |
|
|
| Total
Value |
$65,070,832 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -34.0%
|
-5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 34
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-11-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
540 |
181,501 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,320 |
333,610 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
34,780 |
335,338 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,520 |
8,584 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2019-11-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
450 |
327,070 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2019-12-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
630 |
180,261 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2020-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
35,580 |
296,413 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
44,850 |
310,341 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,282 |
8,982 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2020-07-09 |
4 |
GD |
$0.00 |
$0 |
I/I |
425 |
247,533 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2021-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
41,350 |
337,002 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,923 |
10,844 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2021-12-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
700 |
303,689 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2022-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
34,780 |
338,569 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
40,280 |
378,849 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,144 |
12,988 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-02-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
200 |
100 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-02-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
200 |
247,333 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
167,532 |
487,856 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
36,100 |
523,956 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,505 |
15,493 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2023-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,370 |
425,112 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
143,601 |
563,203 |
0 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • – |
2018-09-24 |
4 |
S |
$0.30 |
$8,002 |
D/D |
(26,619) |
18,500 |
0 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • – |
2018-09-13 |
4 |
S |
$0.47 |
$9,400 |
D/D |
(20,000) |
45,119 |
0 |
- |
|
850 Records found
|
|
Page 3 of 34 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
